EPO, erythropoietin, 2056

N. diseases: 646; N. variants: 11
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0027627
Disease: Neoplasm Metastasis
Neoplasm Metastasis
0.340 AlteredExpression phenotype BEFREE Expression of multidrug resistance protein P-glycoprotein in correlation with markers of hypoxia (HIF-1α, EPO, EPO-R) in invasive breast cancer with metastasis to lymph nodes. 29181060 2017
CUI: C0027627
Disease: Neoplasm Metastasis
Neoplasm Metastasis
0.340 AlteredExpression phenotype BEFREE However, PADI2 might have deleterious effects on tumor growth and metastasis in liver tumor cells by regulating the expression of EPO, a gene with controversial functions in tumor growth. 28331341 2017
CUI: C0027627
Disease: Neoplasm Metastasis
Neoplasm Metastasis
0.340 Biomarker phenotype BEFREE In summary, we show the overexpression of functional EpoR expression in about half of the analyzed clinical melanoma metastasis specimens and show anti-apoptotic as well as pro-migratory effects of Epo, which is of importance for the treatment of anemia in advanced melanoma. 19536148 2010
CUI: C0027627
Disease: Neoplasm Metastasis
Neoplasm Metastasis
0.340 Biomarker phenotype CTD_human Erythropoietin (Epo) and the epo-receptor (EpoR) have been implicated in tumor growth, invasion and metastasis. 16699298 2006
CUI: C0027627
Disease: Neoplasm Metastasis
Neoplasm Metastasis
0.340 Biomarker phenotype BEFREE Increased levels of EPO and EPOR in lymph node metastases as compared to primary tumors from HNSCC patients further support the role of EPO/EPOR in HNSCC disease progression and metastasis. 15856028 2005
CUI: C0027627
Disease: Neoplasm Metastasis
Neoplasm Metastasis
0.340 AlteredExpression phenotype LHGDN Increased levels of EPO and EPOR in lymph node metastases as compared to primary tumors from HNSCC patients further support the role of EPO/EPOR in HNSCC disease progression and metastasis. 15856028 2005